Pharmaceutical Care for a High Paraplegia Patient with Hospital Acquired Pneumonia / 中国药房
China Pharmacy
;
(12): 3729-3730,3731, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-605369
ABSTRACT
OBJECTIVE:
To investigate the role of clinical pharmacists in the treatment of high paraplegia patient with hospital acquired pneumonia.METHODS:
Clinical pharmacists provided suggestions for anti-infective treatment failure of a high paraplegia patient with hospital acquired pneumonia,including anti-infective treatment of imipenem and cilastatin sodi-um 1.0 g,ivgtt,qid,de-escalation anti-infective treatment of cefoperazone sodium and sulbactam sodium 3.0 g,ivgtt,bid+amikacin 0.4 g,ivgtt,bid,and prevention treatment of fluconazole sodium chloride 0.2 g,ivgtt,qd against potential invasive infections with fungi,etc.,assisted physician to improve therapy plan,monitor ADR and guide rational drug use. RE-SULTSAfter 3 weeks of treatment,the symptoms had been improved significantly.CONCLUSIONS:
Clinical pharmacists provide individual pharmaceutical care to reduce ADR during treatment and improve the effectiveness and safety of clinical treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacy
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS